Organ-on-Chip Integrated Into Preclinical Glioblastoma Research
Using Dynamic42’s human-based BBB-on-chip model, the partners will explore how differences between human and non-human BBB-biology can influence therapeutic responses, which is a major factor for limited activity of brain cancer drugs. The post Organ-on-Chip Integrated Into Preclinical Glioblastoma Research appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.